Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Schizophrenia Research

• Publication date

  2004-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.SCHRES.2003.08.014PMID 15469203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia

  2002cited by this paper
• Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers

  2002cited by this paper
• Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice

  2002cited by this paper
• Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia.

  2002influential reference
• Low glial numbers in the amygdala in major depressive disorder.

  2002influential reference
• Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression.

  2001influential reference
• Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.

  2001influential reference
• Reduction in anti-apoptotic protein Bcl-2 in autistic cerebellum

  2001cited by this paper
• Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression

  2000cited by this paper
• Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder

  2000cited by this paper
• Effects of inducible glial fibrillary acidic protein on glioma cell motility and proliferation

  2000cited by this paper
• The stanley foundation brain collection and neuropathology consortium.

  2000cited by this paper
• Mind glue: implications of glial cell biology for psychiatry.

  2000cited by this paper
• Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder.

  2000cited by this paper
• Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

  1999influential reference
• Dysfunctional cortico‐cerebellar circuits cause ‘cognitive dysmetria’ in schizophrenia

  1998cited by this paper
• Glial reduction in the subgenual prefrontal cortex in mood disorders.

  1998influential reference
• Alterations in hippocampal expression of SNAP-25, GAP-43, stannin and glial fibrillary acidic protein following mechanical and trimethyltin-induced injury in the rat.

  1996cited by this paper
• Astrocytes: Form, Functions, and Roles in Disease

  1994cited by this paper
• Na(+)-dependent, fluoxetine-sensitive serotonin uptake by astrocytes tissue-printed from rat cerebral cortex

  1994cited by this paper
• Localization of 5‐HT1A receptors to astroglial cells in adult rats: Implications for neuronal‐glial interactions and psychoactive drug mechanism of action

  1993cited by this paper
• Choline acetyltransferase in schizophrenia.

  1993cited by this paper
• The histochemical demonstration of MPTP oxidation in the postmortem human striatum.

  1993cited by this paper
• Distribution of Glial Fibrillary Acidic Protein in Gliosed Human White Matter

  1986cited by this paper
• Glial fibrillary acidic protein (GFAP) in ependymal cells during development. An immunocytochemical study.

  1980cited by this paper

• Cerebellar astrocytic alterations in depression

  2026cites this paper
• Genetic and epigenetic analysis of plasma glial fibrillary acidic protein (GFAP) levels in PTSD

  2025cites this paper
• When the Stars Misfire: Astrocytic Dysfunctions in Major Depressive Disorder

  2025cites this paper
• Chamomile Modulates Glucose Metabolism and Neuro-inflammation to Alleviate Stress-Induced Depression in Mice

  2025cites this paper
• Oxidative stress in the cerebellum of pinealectomized rats and its correlation with GFAP expression

  2025cites this paper
• Neuroglia in mood disorders.

  2025cites this paper
• Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder

  2025cites this paper
• The potential ameliorative effect of mesenchymal stem cells-derived exosomes on cerebellar histopathology and their modifying role on PI3k-mTOR signaling in rat model of autism spectrum disorder

  2025cites this paper
• Third-Generation Antipsychotics: The Quest for the Key to Neurotrophism

  2025cites this paper
• Chronic activation of a negative engram induces behavioral and cellular abnormalities

  2024cites this paper
• Serum glial fibrillary acidic protein and neurofilament light chain in treatment-naïve patients with unipolar depression.

  2023cites this paper
• Serum Levels of S100B Protein and Myelin Basic Protein as a Potential Biomarkers of Recurrent Depressive Disorders

  2023cites this paper
• Glymphatic System Dysfunction in Central Nervous System Diseases and Mood Disorders

  2022cites this paper
• The Blood-Brain Barrier in Bipolar Disorders: A Systematic Review

  2022cites this paper
• Gene Enrichment Analysis of Astrocyte Subtypes in Psychiatric Disorders and Psychotropic Medication Datasets

  2022cites this paper
• Glial Cell Abnormalities in Major Psychiatric Diseases: A Systematic Review of Postmortem Brain Studies

  2022cites this paper
• Detection of Microstructural Medial Prefrontal Cortex Changes Using Magnetic Resonance Imaging Texture Analysis in a Post-Traumatic Stress Disorder Rat Model

  2022cites this paper
• Assessing the relationships between neurological and psychiatric diseases with astrocyte subtypes and psychotropic medications

  2021influential citation
• Astrocytes in Neuropsychiatric Disorders: A Review of Postmortem Evidence.

  2021cites this paper
• Implication of cerebral astrocytes in major depression: A review of fine neuroanatomical evidence in humans

  2021cites this paper
• Immune mechanisms in bipolar disorder: Evidence and implications

  2021cites this paper
• Cerebellar Connections with Limbic Circuits: Anatomy and Functional Implications

  2021cites this paper
• Glymphatic Dysfunction: A Bridge Between Sleep Disturbance and Mood Disorders

  2021cites this paper
• Glial Cells in the Schizophrenia Puzzle: Angiotensin II Role

  2021cites this paper
• Role of Astrocytes in Major Neuropsychiatric Disorders

  2021cites this paper
• Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression

  2021cites this paper
• Neuroinflammatory Basis of Depression: Learning From Experimental Models

  2021cites this paper
• Widespread Decrease of Cerebral Vimentin-Immunoreactive Astrocytes in Depressed Suicides

  2020cites this paper
• Brain Structural Abnormalities of Major Depressive Disorder

  2020cites this paper
• Connexin 43: A novel ginsenoside Rg1-sensitive target in a rat model of depression.

  2020cites this paper
• Contribution of glia cells specifically astrocytes in the pathology of depression: immunohistochemical study in different brain areas.

  2020cites this paper
• Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role?

  2020cites this paper
• Neurons and glial cells in bipolar disorder: a systematic review of postmortem brain studies of cell number and size.

  2019cites this paper
• Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review

  2019cites this paper
• Quinolinic Acid and Nuclear Factor Erythroid 2-Related Factor 2 in Depression: Role in Neuroprogression

  2019cites this paper
• Stress‐induced structural and functional modifications of astrocytes—Further implicating glia in the central response to stress

  2019cites this paper
• Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.

  2019cites this paper
• Human astrocytes in the diseased brain

  2018cites this paper
• Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders

  2018cites this paper
• Aminochrome decreases NGF, GDNF and induces neuroinflammation in organotypic midbrain slice cultures

  2018cites this paper
• Impaired integrity of the brain parenchyma in non-geriatric patients with major depressive disorder revealed by diffusion tensor imaging

  2018cites this paper
• Hippocampal astrocyte atrophy in a mouse depression model induced by corticosterone is reversed by fluoxetine instead of benzodiazepine diazepam

  2018cites this paper
• (Micro)Glia as Effectors of Cortical Volume Loss in Schizophrenia.

  2018cites this paper
• Self‐injurious behaviours in rhesus macaques: Potential glial mechanisms

  2018cites this paper
• FUNCTIONAL RELATIONSHIP BETWEEN GUT MICROBIOTA AND ANXIETY THE FUNCTIONAL RELATIONSHIP BETWEEN THE GUT MICROBIOTA AND GENERALIZED ANXIETY DISORDER IN THE MURINE MODEL By

  2017cites this paper
• Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis

  2017cites this paper
• Origen y consecuencias de la inflamación en depresión

  2017cites this paper
• Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies

  2017cites this paper
• Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review

  2016cites this paper
• Synaptic Plasticity, Metaplasticity and Depression

  2016cites this paper
• Astroglia, Glutamatergic Transmission and Psychiatric Diseases.

  2016cites this paper
• Glial fibrillary acidic protein is differentially expressed across cortical and subcortical regions in healthy brains and downregulated in the thalamus and caudate nucleus of depressed suicides

  2016cites this paper
• Exploring the Role of Inflammatory Cytokines in the Pathophysiology, Cognitive Dysfunction and Treatment of Bipolar Disorder: Integrative Evidence Provided by a Proof-of-Concept Study with Adjunctive Minocycline

  2016cites this paper
• Serum levels of glial fibrillary acidic protein and Nogo-A in children with autism spectrum disorders

  2016cites this paper
• Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques.

  2015cites this paper
• Glia‐related genes and their contribution to schizophrenia

  2015cites this paper
• Astrocyte and Microglial Control of Glutamatergic Signalling: A Primer on Understanding the Disruptive Role of Chronic Stress

  2015cites this paper
• FGF2 alleviates PTSD symptoms in rats by restoring GLAST function in astrocytes via the JAK/STAT pathway.

  2015cites this paper
• Glial abnormalities in substance use disorders and depression: Does shared glutamatergic dysfunction contribute to comorbidity?

  2014cites this paper
• Calcium Dyshomeostasis in White Matter Injury

  2014cites this paper
• Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum

  2014cites this paper
• Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

  2014cites this paper
• Impaired integrity of the brain parenchyma in non-geriatric patients with major depressive disorder revealed by diffusion tensor imaging.

  2013cites this paper
• Roles of glial cells in schizophrenia: possible targets for therapeutic approaches.

  2013cites this paper
• Cerebellar vermis volume in major depressive disorder

  2013cites this paper
• Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder.

  2013cites this paper
• Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

  2013cites this paper
• Glial degeneration as a model of depression

  2013cites this paper
• Metabolomic identification of molecular changes associated with stress resilience in the chronic mild stress rat model of depression

  2013cites this paper
• Chronic administration of risperidone in a rat model of schizophrenia: a behavioural, morphological and molecular study.

  2013cites this paper
• In vitro effect of antipsychotics on brain energy metabolism parameters in the brain of rats

  2013cites this paper
• FGF2 blocks PTSD symptoms via an astrocyte-based mechanism.

  2013cites this paper
• From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.

  2013cites this paper
• Effects of early-life administration of methamphetamine on the depressive-like behaviour later in life in stress-sensitive and control rats

  2013cites this paper
• Chronic Fluoxetine Administration during Different Postnatal Development Stages Leads to Stage Dependent Changes of Glial Fibrillary Acidic Protein Expression in Rat Brain

  2012cites this paper
• Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

  2012cites this paper
• Depressive-like behavior in adrenocorticotropic hormone-treated rats blocked by memantine.

  2012cites this paper
• Astrocytes in Major Depressive Disorder and Schizophrenia: Pathophysiological and Therapeutic Aspects

  2011cites this paper
• The Role of Glial Pathology in Autism

  2011cites this paper
• The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

  2011cites this paper
• Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: a voxel-based morphometry study.

  2011cites this paper
• Prenatal Viral Infection in Mouse: An Animal Model of Schizophrenia

  2011cites this paper
• Regulation and Pharmacological Manipulation of the Type 5 Metabotropic Glutamate (mGlu5) Receptor

  2011cites this paper
• The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithium

  2011cites this paper
• Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers.

  2011cites this paper
• Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

  2010cites this paper
• alcium dyshomeostasis in white matter pathology

  2010cites this paper
• Is there a CSF biomarker profile related to depression in elderly women?

  2010cites this paper
• Calcium dyshomeostasis in white matter pathology.

  2010cites this paper
• Inflammation and Mood Disorders: Proinflammatory Cytokines and the Pathogenesis of Depression

  2010cites this paper
• High-field magnetic resonance imaging of suicidality in patients with major depressive disorder.

  2010cites this paper
• Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs.

  2009cites this paper
• Brain abnormalities in schizophrenia

  2009cites this paper
• A role for astroctye-related genes in suicide

  2009cites this paper
• S100B – A common connection between depression and cerebellar disorders

  2009cites this paper
• Sleep-Disordered Breathing, Physiological Sequelae, and the Neurobiological Relationship with Psychopathology

  2009cites this paper
• Targeting glial physiology and glutamate cycling in the treatment of depression.

  2009cites this paper
• ffects of olanzapine , fluoxetine and olanzapine / fluoxetine on creatine kinase ctivity in rat brain

  2009cites this paper
• Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia.

  2008cites this paper
• Inflammation, Glutamate, and Glia in Depression: A Literature Review

  2008cites this paper